Publikationen in Zusammenarbeit mit Forschern von University of Texas Health Science Center at San Antonio (22)

2024

  1. Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure

    LIFE-BASEL, Vol. 14, Núm. 1

2022

  1. Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  2. Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 3

2021

  1. Melatonin and Cardioprotection in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Frontiers in Cardiovascular Medicine, Vol. 8

2020

  1. Melatonin as a putative protection against myocardial injury in COVID-19 infection

    Expert Review of Clinical Pharmacology

  2. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!

    Revista Espanola de Cardiologia

  3. Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19

    Frontiers in Medicine, Vol. 7

2017

  1. Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei

    International Journal of Cardiology

  2. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial

    Journal of Pineal Research, Vol. 62, Núm. 1

  3. Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time

    Cardiovascular Drugs and Therapy

  4. Melatonin for cardioprotection in ST elevation myocardial infarction: Are we ready for the challenge?

    Heart

  5. Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)

    American Journal of Cardiology, Vol. 120, Núm. 4, pp. 522-526

2016

  1. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony

    International Journal of Cardiology, Vol. 221, pp. 359-363

2014

  1. The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy

    International Journal of Cardiology, Vol. 174, Núm. 2, pp. 415-417

2013

  1. Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: A two-dimensional speckle tracking study

    Biomarkers, Vol. 18, Núm. 4, pp. 310-313

2010

  1. Melatonin and circadian biology in human cardiovascular disease

    Journal of Pineal Research, Vol. 49, Núm. 1, pp. 14-22

2009

  1. Clinical aspects of melatonin in the acute coronary syndrome

    Current Vascular Pharmacology, Vol. 7, Núm. 3, pp. 367-373

2008

  1. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction

    Atherosclerosis, Vol. 199, Núm. 1, pp. 73-78

  2. Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction

    Journal of Pineal Research, Vol. 44, Núm. 1, pp. 65-69

2007

  1. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty. The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: Study design and rationale

    Contemporary Clinical Trials, Vol. 28, Núm. 4, pp. 532-539